The securities litigation law firm of Brower Piven, A Professional
Corporation, has commenced an investigation into possible breaches of
fiduciary duty and other violations of state law by the Board of
Directors of LipoScience, Inc. (“LipoScience” or the “Company”) (Nasdaq:
LPDX) relating to the proposed buyout of the Company by Laboratory
Corporation of America Holdings (“LabCorp”).
On September 25, 2014 LipoScience and LabCorp announced the signing of a
definitive merger agreement pursuant to which LabCorp will acquire
LipoScience in a transaction valued at approximately $85.3 million.
for - SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of LipoScience, Inc. And Encourages Investors To Contact The Firm For Additional Information investment picks